CUTAQUIG DIN 02473003
Status: Approved
Holder: OCTAPHARMA PHARMAZEUTIKA PRODUKTIONSGES M B H
Molecule: IMMUNOGLOBULIN G (HUMAN)
Health Canada record
| Active ingredient(s) | IMMUNOGLOBULIN G (HUMAN) 1.65 G |
|---|---|
| Dosage form | Solution |
| Route | Subcutaneous |
| Schedule | SCHEDULE D |
| Class | Human |
| ATC | J06BA01 IMMUNOGLOBULINS, NORMAL HUMAN, FOR EXTRAVASC. ADM |
| Original market date | |
| Current status date | 15-Feb-2018 |
| Source | Health Canada DPD |
Establishment licence of the holder
Octapharma Pharmazeutika Produktionsges m.b.H. — licence , not currently licensed, last inspection rating C (2024-10-10).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing IMMUNOGLOBULIN G (HUMAN)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02473038 | CUTAQUIG | OCTAPHARMA PHARMAZEUTIKA PRODUKTIONSGES M B H | Solution | IMMUNOGLOBULIN G (HUMAN) 3.3 G | Approved |
| 02472996 | CUTAQUIG | OCTAPHARMA PHARMAZEUTIKA PRODUKTIONSGES M B H | Solution | IMMUNOGLOBULIN G (HUMAN) 1 G | Dormant |
| 02473011 | CUTAQUIG | OCTAPHARMA PHARMAZEUTIKA PRODUKTIONSGES M B H | Solution | IMMUNOGLOBULIN G (HUMAN) 2 G | Dormant |
| 02473046 | CUTAQUIG | OCTAPHARMA PHARMAZEUTIKA PRODUKTIONSGES M B H | Solution | IMMUNOGLOBULIN G (HUMAN) 4 G | Dormant |
| 02473054 | CUTAQUIG | OCTAPHARMA PHARMAZEUTIKA PRODUKTIONSGES M B H | Solution | IMMUNOGLOBULIN G (HUMAN) 8 G | Dormant |
| 02282518 | VIVAGLOBIN | CSL BEHRING CANADA INC | Solution | IMMUNOGLOBULIN G (HUMAN) 160 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 20489 | 2018-02-15 | New Drug Submission (NDS) |